Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04778449

Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma

Status
Recruiting
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
M.D. Anderson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study investigates the extent to which lifestyle factors including mental health, social support, diet, and exercise are associated with quality of life and melanoma patient outcomes. Knowledge gained from this study may be used to guide the design of prospective clinical trials of lifestyle interventions to improve the outcomes of melanoma patients and assist doctors in counseling their patients.

Detailed description

PRIMARY OBJECTIVES: I. Collect systematic data on mental health, quality of life (QOL), social support, diet, and exercise behaviors in melanoma patients. II. Examine whether psychosocial factors and lifestyle are associated with clinical outcomes in melanoma patients. III. Examine the association between lifestyle and psychosocial factors and tissue and blood biomarkers in melanoma patients. IV. Examine whether psychosocial factors and lifestyle are associated with QOL adjustment in melanoma patients. OUTLINE: Patients complete a maximum of 3 paper or electronic questionnaires over 30 minutes within 2 weeks of presentation to MD Anderson, new diagnosis of melanoma, and/or initiating a new treatment, within 2 weeks of first restaging, and within 2 weeks of the end of treatment. Patients may complete an additional paper or electronic dietary questionnaire over 10 minutes for 3 days (30 minutes total) or a phone-based dietary recall. Patients who start a new treatment of interest may repeat the questionnaires at the same time points. Patients' medical records are also reviewed.

Conditions

Interventions

TypeNameDescription
OTHERMedical Chart ReviewMedical charts are reviewed
OTHERQuestionnaire AdministrationComplete questionnaires

Timeline

Start date
2015-08-26
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2021-03-03
Last updated
2025-10-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04778449. Inclusion in this directory is not an endorsement.